Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology
INDIANAPOLIS and SOUTH SAN FRANCISCO, Calif., June 20, 2023 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) and DICE Therapeutics, Inc. (NASDAQ: DICE) today announced a definitive agreement for Lilly to acquire DICE.
DICE... Biopharmaceuticals, Mergers & Acquisitions Eli Lilly, DICE Therapeutics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news